Latest news
Debiopharm Group™ moves forward three of its oncology clinical programs and will present the recent progresses at the 50th American…
Orient EuroPharma and Debiopharm Group™ announce their partnership and the launch of Pamorelin LA in Singapore
Evotec and Debiopharm Group™ to collaborate on development of new treatment for cancer
Curis and Debiopharm Group™ Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014
Debiopharm Group™ to Acquire Products or Companies to Expand Activities at Manufacturing Facility in Martigny (Valais, Switzerland)
Debiopharm Group™ and Yale University extend and broaden their collaboration for the discovery and development of MIF inhibitors to treat…
Debiopharm Group™ to Acquire Affinium’s Antibiotic Clinical Assets and Platform to Identify and Develop Targeted Antibiotics
Debiopharm Group™ Announces Completion of Recruitment for Phase III Clinical Study with Triptorelin 22.5 mg in Central Precocious Puberty
Stay informed
Don't miss any latest news and announcements on Debiopharm Investment, subscribe to our newsletter.